Pro- and Anti-inflammatory Cytokines in PCOS

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-45
SponsorJagiellonian University

About this trial

The study will involve measurements and comparisons of the concentrations of pro-inflammatory cytokines: IL-6, TNF-α, IL-18, as well as anti-inflammatory cytokine IL-4 in women with polycystic ovary syndrome (PCOS) and insulin resistance, women with polycystic ovary syndrome without carbohydrate metabolism disorders, and women without PCOS (control group).

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

women aged 18-45 years

Disqualifiers

previous removal of at least one ovary

treated diabetes of any type

diagnosed and treated metabolic diseases

diagnosed and treated autoimmune diseases

Trial population

women aged 18-45 years, managed for menstrual irregularities, infertility or for routine check-up

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Measurement of interleukin-6 (il-6) concentration in blood serum

    Diagnostic test

    Measurement of fasting interleukin-6 (il-6) concentration in fasting venous blood serum

  • Measurement of fasting tumor necrosis factor α (TNF-α) concentration

    Diagnostic test

    Measurement of fasting tumor necrosis factor α concentration in fasting venous blood serum

  • Measurement of interleukin-18 (il-18) concentration

    Diagnostic test

    Measurement of interleukin-18 (il-18) concentration in fasting venous blood serum

  • Measurement of interleukin-4 (il-4) concentration

    Diagnostic test

    Measurement of interleukin-4 (il-4) concentration in fasting venous blood plasma

Treatment groups

100 Participants
are divided into 3 treatment groups
Group A: Polycystic ovary syndrome (PCOS)+ insulin resistance (IR)4 interventions
Group B: Polycystic ovary syndrome (PCOS)+ no insulin resistance (IR)4 interventions
Group C: No PCOS4 interventions

Trial outcomes

Primary outcomes

1

Il-6 concentration

Measurement and comparison of serum interleukin-6 (il-6) concentration expressed in \[pg/ml\] in three research groups

Time frame
up to 6 months
2

Il-18 concentration

Measurement and comparison of serum interleukin-18 (il-18) concentration expressed in \[pg/ml\] in three research groups

Time frame
up to 6 months
3

Il-4 concentration

Measurement and comparison of serum interleukin-4 (il-4) concentration expressed in \[pg/ml\] in three research groups

Time frame
up to 6 months
4

TNF-α concentration

Measurement and comparison of serum tumor necrosis factor α (TNF-α) concentration expressed in \[pg/ml\] in three research groups

Time frame
up to 6 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.